Ariis

Founded in 2010, the Alliance for Research and Innovation in the Health Industries (ariis) comprises pharmaceutical, medical device, in vitro diagnostics, and digital health industry members globally. As an interface between healthcare companies and French public research, our mission is to catalyse synergies between public and private research and innovation actors, enhancing their international appeal.

STRENGTHENING THE UNDERSTANDING OF PUBLIC RESEARCH ORGANIZATION

PREPARING FOR THE NEXT CHALLENGES FACING HEALTHCARE COMPANIES

FACILITATING NEW PUBLIC-PRIVATE COLLABORATIONS

SHARING INDUSTRIAL R&D CHALLENGES WITH PUBLIC AUTHORITIES

"Innovation doesn't happen in isolation, but collectively"

ariis aims to enhance dialogue and mutual understanding between public entities (government agencies, upstream or applied research structures) and private stakeholders in health research and innovation. Indeed, innovation doesn’t happen in isolation but through collaboration, requiring the establishment of long-term partnerships where various public and private actors get to know each other and collaborate. To achieve this, ariis organizes symposiums and roundtable discussions on jointly identified topics. The Alliance also seeks to promote the establishment of internationally visible innovation ecosystems capable of offering disruptive solutions in response to the rapid evolution of our healthcare systems.

1971
AFRT
Establishment of AFRT (French Association for Therapeutic Research)
2004
LEEM Research
AFTR becomes LEEM Research
2010
ariis
Creation of AVIESAN

With the establishment of AVIESAN, LEEM Research becomes ariis, and the Alliance expands to include all health industry players. ariis moves to new premises shared with FEFIS.

Presidents of ariis:

2010-2011: Pierre Teillac (Pierre Fabre)       

2011-2017: Claude Bertrand (IPSEN) Since

2017
ariis
ariis relocates to new premises with FEFIS.

President of ariis:

Since 2017: Marc Bonneville (Institut Mérieux)

2021
ariis moves to Paris Santé Campus.